Advisor Group Holdings, Inc. Petros Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$1.07 - $3.36 $749 - $2,352	-700 Reduced 38.15%	1,135 $2,000
Q3 2021 Nov 05, 2021	SELL	$1.82 - $3.2 $1,201 - $2,112	-660 Reduced 26.45%	1,835 $4,000
Q2 2021 Aug 02, 2021	BUY	$2.87 - $4.11 $1,722 - $2,466	600 Added 31.66%	2,495 $8,000
Q1 2021 May 13, 2021	SELL	$2.85 - $4.6 $1,710 - $2,760	-600 Reduced 24.05%	1,895 $7,000
Q4 2020 Feb 10, 2021	BUY	$3.24 - $4.68 $8,083 - $11,676	2,495 New	2,495 $11,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $6.42M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.